Cited by 841Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular PreventionCardiovascular Health and Risk Factors

The DOI matches its Crossref record, with a small difference in title or year; 27 of the 27 references it cites were found in a registry or an index.

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Open access

Ridker, Paul M, Paynter, Nina P., Rifai, Nader, Gaziano, J. Michael, Cook, Nancy R.·2008·Circulation

DOI 10.1161/circulationaha.108.814251PMC PMC2752381

Open this paper in CoChat — free account Open PDF

Abstract

Background— High-sensitivity C-reactive protein and family history are independently associated with future cardiovascular events and have been incorporated into risk prediction models for women (the Reynolds Risk Score for women); however, no cardiovascular risk prediction algorithm incorporating these variables currently exists for men. Methods and Results— Among 10 724 initially healthy American nondiabetic men who were followed up prospectively over a median period of 10.8 years, we compared the test characteristics of global model fit, discrimination, calibration, and reclassification in 2 prediction models for incident cardiovascular events, one based on age, blood pressure, smoking status, total cholesterol, and high-density lipoprotein cholesterol (traditional model) and the other based on these risk factors plus high-sensitivity C-reactive protein and parental history of myocardial infarction before age 60 years (Reynolds Risk Score for men). A total of 1294 cardiovascular events accrued during study follow-up. Compared with the traditional model, the Reynolds Risk Score had better global fit (likelihood ratio test P <0.001), a superior (lower) Bayes information criterion, and a larger C-index ( P <0.001). For the end point of all cardiovascular events, the Reynolds Risk Score for men reclassified 17.8% (1904/10 724) of the study population (and 20.2% [1392/6884] of those at 5% to 20% 10-year risk) into higher- or lower-risk categories, with markedly improved accuracy among those reclassified. For this model comparison, the net reclassification index was 5.3%, and the clinical net reclassification index was 14.2% (both P <0.001). In models based on the Adult Treatment Panel III preferred end point of coronary heart disease and limited to men not taking lipid-lowering therapy, 16.7% of the study population (and 20.1% of those at 5% to 20% 10-year risk) were reclassified to higher- or lower-risk groups, again with significantly improved global fit, larger C-index ( P <0.001), and markedly improved accuracy among those reclassified. For this model, the net reclassification index was 8.4% and the clinical net reclassification index was 15.8% (both P <0.001). Conclusions— As previously shown in women, a prediction model in men that incorporates high-sensitivity C-reactive protein and parental history significantly improves global cardiovascular risk prediction.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1161/circulationaha.108.814251

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Magnesium Replacement Improves the Metabolic Profile in Obese and Pre-Diabetic Patients with Mild-to-Moderate Chronic Kidney Disease: A 3-Month, Randomised, Double-Blind, Placebo-Controlled Study
Toprak, Ö., Kurt, H., Sarı, Y., Şarkış, C., Us, H., & Kırık, A. (2017) · Kidney & Blood Pressure Research · doi:10.1159/000468530 · Cited by 29,772
Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)
Grundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,944
Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Regression Modeling Strategies
Harrell, F. E. (2001) · Springer series in statistics · doi:10.1007/978-1-4757-3462-1 · Cited by 9,270
General Cardiovascular Risk Profile for Use in Primary Care: The Framingham Heart Study
D’Agostino, R. B., Vasan, R. S., Pencina, M. J., Wolf, P. A., Cobain, M., Massaro, J. M., & Kannel, W. B. (2008) · Circulation · doi:10.1161/circulationaha.107.699579 · Cited by 7,491
Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis
Harrell (2015) · Springer Series in Statistics · doi:10.1007/978-3-319-19425-7 · Cited by 6,878
Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond
Pencina, M. J., D' Agostino, R. B., D' Agostino, R. B., & Vasan, R. S. (2008) · Statistics in Medicine · doi:10.1002/sim.2929 · Cited by 6,493
Use and Misuse of the Receiver Operating Characteristic Curve in Risk Prediction
Cook, N. R. (2007) · Circulation · doi:10.1161/circulationaha.106.672402 · Cited by 2,156
Self-citation
Development and Validation of Improved Algorithms for the Assessment of Global Cardiovascular Risk in Women: The Reynolds Risk Score
Ridker, P. M., Buring, J. E., Rifai, N., & Cook, N. R. (2007) · JAMA · doi:10.1001/jama.297.6.611 · Cited by 1,814
Self-citation

Show all 27 references

Research works printed but not linked: 2

10.1161/circ.86.5.1330360 · DOI
10.1161/hyp.39.1.105 · DOI

Sorted by citations

Items 701–800 of 840

ACCF/AHA Practice Guideline
Yancy, C. W., Jessup, M. L., Bozkurt, B., Butler, J., Drazner, M. H., Fonarow, G. C., Geraci, S. A., Horwich, T. B., Januzzi, J. L., Johnson, M. R., et al. (2013) · Cited by 1
Cardiovascular Autonomic Neuropathy: Risk Factor or Risk Indicator
Colombo, J., Arora, R. R., DePace, N. L., & Vinik, A. I. (2014) · Springer eBooks · doi:10.1007/978-3-319-07371-2_9 · Cited by 1
Guidelines Cardiology Foundation/American Heart Association Task Force on Practice of Asymptomatic Adults: Executive Summary: A Report of the American College 2010 ACCF/AHA Guideline for Assessment of Cardiovascular Risk in
Jacobs, A. K., Smith, S. C., Taylor, A. J., Weintraub, W. S., Kushner, F. G., Lauer, M. S., Benjamin, J. M., Budoff, M. J., Fayad, Z. A., Foster, E., et al. (2011) · Cited by 1
Implementation of the 2013 American College of Cardiology/American Heart Association Blood Cholesterol Guideline Including Data From the Improved Reduction of Outcomes: Vytorin Efficacy International Trial
Ziaeian, B., Dinkler, J., & Watson, K. E. (2015) · Reviews in Cardiovascular Medicine · doi:10.3909/ricm0762 · Cited by 1
Initial Evaluation and Approach to the Patient with Hypertension
Krousel-Wood, M. A., Materson, B. J., & Whelton, P. K. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3358-5.50036-x · Cited by 1
Childhood Obesity
Suh, S., & Kim, Y.-S. (2012) · CRC Press eBooks · doi:10.1201/b12261-66 · Cited by 1
Prediction of Global Cardiovascular Risk in Hypertension
Wilson, P. W. F. (2007) · Elsevier eBooks · doi:10.1016/b978-1-4160-3053-9.50022-6 · Cited by 1
Childhood Obesity: Exercise Physiologists' Perspective
Suh, S., & Kim, Y.-S. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-812840-4.00006-2 · Cited by 1
Prediction of Global Cardiovascular Risk in Hypertension
Wilson, P. W. F. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4377-2766-1.00016-8 · Cited by 1
Predictive value of vascular response to cuff inflation–induced pain in the control arm for adverse cardiovascular events
Sun, T., Matsuzawa, Y., Widmer, R. J., Hermann, J., Lerman, L. O., & Lerman, A. (2021) · IJC Heart & Vasculature · doi:10.1016/j.ijcha.2021.100728 · Cited by 1
Risk Factors for Cardiovascular Diseases in Aircrew
Buila, N. B., Kabanda, G., Munyoka, E. M.-C., Bantu, J.-M. B., & M’buyamba-Kabangu, J. R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.99905 · Cited by 1
Epidemiology of Atherosclerotic Vascular Diseases
Andersson, C., & O’Donnell, C. J. (2015) · Springer eBooks · doi:10.1007/978-3-642-37078-6_46 · Cited by 1
Diving Medicine
Meintjes, W. A. J. (2018) · Elsevier eBooks · doi:10.1016/b978-0-323-54696-6.00043-4 · Cited by 1
Transparent Reporting of a Multivariable Prediction Model for Individual Prognosis or Diagnosis (TRIPOD): Explanation and Elaboration. Translation into Russian
Moons, K. G. M., Altman, D. G., Reitsma, J. B., loannidis, J. P. A., Macaskill, P., Steyerberg, E. W., Vickers, A. J., Ransohoff, D. F., & Collins, P. G. S. (2023) · Вопросы современной педиатрии · doi:10.15690/vsp.v22i2.2557 · Cited by 1
Cardiovascular risk assessment: The key path toward precision prevention
Li, J., & Lu, X. (2023) · Chronic Diseases and Translational Medicine · doi:10.1002/cdt3.90 · Cited by 1
Behavioral, Clinical, and Coronary Artery Calcium Screening for Prevention and Treatment of Subclinical Atherosclerosis: Implications for Health Education
Fine, J. J., Valois, R. F., & Kammermann, S. K. (2024) · American Journal of Health Education · doi:10.1080/19325037.2024.2390400 · Cited by 1
Biology of Aging and Implications for Heart Failure Therapy and Prevention
Jugdutt, B. I. (2014) · Springer eBooks · doi:10.1007/978-1-4939-0268-2_2 · Cited by 1
Selecting Valid Questionnaires for a Longitudinal Study of African-American College Student Health
Collins, M. P. (2014) · CORE Scholar (Wright State University) · Cited by 1
Genomic Biomarkers in Human Population Studies
Danik, J. S., Paynter, N. P., & Ridker, P. M. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-382227-7.00021-5 · Cited by 1
Self-citation
To Estimate or Not to Estimate Cardiovascular Risk? That is the Question
de Oliveira, G. M. M. (2015) · International Journal of Cardiovascular Sciences · doi:10.5935/2359-4802.20150001 · Cited by 1
Cardiovascular disease risk evaluation
Rollefstad, S., Crowson, C. S., van Riel, P. L. C. M., & Semb, A. G. (2016) · Springer eBooks · doi:10.1007/978-3-319-26782-1_4 · Cited by 1
SÍNDROME METABÓLICA E DOENÇAS CARDIOVASCULARES: DO CONCEITO AO TRATAMENTO
Ferreira, M. E. (2016) · Arquivos Catarinenses de Medicina · doi:10.63845/swbssf51 · Cited by 1
Progress of Genomics in Atherosclerosis-Coronary Heart Disease and Myocardial Infarction
Yuan, J., & Liu, Y. (2018) · Translational bioinformatics · doi:10.1007/978-981-13-1429-2_8 · Cited by 1
Assessment of cardiovascular risk in patients with chronic kidney disease –A study from a tertiary care centre in south India
Sandeep, P., Bitla, A. R. R., Sarvari, G., SrinivasaRao, P. V. L. N., HariniDevi, N., & Kumar, S. (2018) · Journal of Indian College of Cardiology · doi:10.1016/j.jicc.2018.11.009 · Cited by 1
A model-based concordance-type index for evaluating the added predictive ability of novel risk factors and markers in the logistic regression models
Rahman, M. S., & Rumana, A. S. (2019) · Journal of Applied Statistics · doi:10.1080/02664763.2019.1580253 · Cited by 1
Aerobic Exercise Improves Brain Natriuretic Peptide and C-Reactive Protein Among Men and Women With Coronary Artery Disease
sheikhian, N., Ostovan, M. A., Daryanoosh, F., & Sharifi, F. (2018) · International Journal of Applied Exercise Physiology · doi:10.30472/ijaep.v7i4.309 · Cited by 1
Cardiovascular involvement after liver transplantation: role of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis
Lombardi, R., Pisano, G., Fargion, S. R., & Fracanzani, A. L. (2021) · Exploration of Medicine · doi:10.37349/emed.2021.00030 · Cited by 1
High Density Lipoproteins, Dyslipidemia, and Heart Disease: Past, Present, and Future
Schaefer, E. J., & Santos, R. D. (2010) · Springer eBooks · doi:10.1007/978-1-4419-1059-2_23 · Cited by 1
Is there evidence of social inequity in healthcare for coronary heart disease? an electronic-cohort analysis using record-linked, routine data
King, W. (2015) · ORCA Online Research @Cardiff (Cardiff University) · Cited by 1
Cystatin C and the relation to cardiovascular disease : studies on the relative importance of genetic and environmental factors
Arpegård, J. (2015) · Figshare · Cited by 1
Was the FDA misled by JUPITER?
MacDonald, G. P. (2010) · PubMed · Cited by 1
Ronda clínica y epidemiológica
Uribe, Ó. O., & Tobón, J. J. Z. (2008) · IATREIA · doi:10.17533/udea.iatreia.4439 · Cited by 1
Treat-to-Target Low-Density Lipoprotein Cholesterol
Joven, J., Martín-Paredero, V., & Camps, J. (2013) · Angiology · doi:10.1177/0003319713507331 · Cited by 1
Halyos: A patient-facing visual EHR interface for longitudinal risk awarenessPreprint
Mataraso, S. J., Socrates, V., Lekschas, F., & Gehlenborg, N. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/597583 · Cited by 1
Lipid metabolism
Young, I. S., & Gaw, A. (2012) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e328358247d · Cited by 1
Improving cardiac care delivery using predictive and prescriptive analytics
Salah, H. (2022) · doi:10.32469/10355/91687 · Cited by 1
Prevention of Coronary Atherosclerosis
Figtree, G. A., Kott, K. A., & Vernon, S. T. (2023) · Springer eBooks · doi:10.1007/978-3-031-25879-4_3 · Cited by 1
N–terminal prohormone B–type natriuretic peptide, inflammation and the vasculature : exploring the links in a bi–ethnic South African population
Kruger, R. (2012) · Cited by 1
The relevance of specific c–reactive protein genetic variants towards cardiovascular disease risk in a black South African population undergoing an epidemiological transition
Swanepoel, B. (2013) · Cited by 1
Soluble urokinase plasminogen activator receptor and cardiovascular function in African and Caucasian populations : the SAfrEIC study
Smith, A. D. (2010)
Cardiovascular risk prediction in the Netherlands
van Dis, S. J. (2011) · doi:10.18174/186623
The Use of Reynolds Risk Score in Cardiovascular Risk Assessment in Apparently Healthy Bosnian Men and Women: Cross-Sectional Study
Zairagi, A. (2012) · InTech eBooks · doi:10.5772/39018
Obesity, Inflammation, and Vascular Disease: Novel Insight in the Role of Adipose Tissue
Calabrò, P., Golia, E., Maddaloni, V., Limongelli, G., Ziello, B., Fimiani, F., Romano, I. J., Crisci, M., Russo, M. G., Yeh, E. T. H., et al. (2013) · Wiley eBooks · doi:10.1002/9781118395318.ch19
Consecuencias clínicas de la persistencia de actividad inflamatoria en la arteritis de células gigantes. Estudio de factores implicados
Martínez, A. G. (2010) · TDX (Tesis Doctorals en Xarxa)
Vascular Inflammation: A New Horizon in Cardiovascular Risk Assessment
Hegde, V., & Ching, I. (2012) · InTech eBooks · doi:10.5772/32424
New Biomarkers of Cardiovascular Disease in Diabetes
Patel, H. C., Chandran, S., & Ray, K. K. (2014) · Wiley eBooks · doi:10.1002/9781118337967.ch2
Assessment of High Cardiovascular Risk Profiles for the Clinician
Whayne, T. F. (2013) · Angiology · doi:10.1177/0003319712461295
Cardiovascular Disease Risk Assessment: a Review of Risk Factor-based Algorithms and Assessments of Vascular Health
Carrubba, C. J., Blaha, M. J., Nasir, K., & DeFilippis, A. P. (2014) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-014-0419-0
Novel Biomarkers of Cardiovascular Disease
Welch, T. S. (2012) · Springer eBooks · doi:10.1007/978-1-4471-4288-1_3
Secondary tests for stratification of risk for atherosclerosis
Wierzbicki, A. S., & Reynolds, T. (2013) · Current Medical Research and Opinion · doi:10.1185/03007995.2013.794133
Does Cardiovascular Ultrasound Have a Role in Assessment of Cardiovascular Risk in Asymptomatic Persons?
Waller, A. H., & Gardin, J. M. (2012) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-012-0225-5
Biomarker science: direction for the scientific community
Becker, R. C. (2009) · Journal of Thrombosis and Thrombolysis · doi:10.1007/s11239-009-0323-5
Islands in the Stream: The Risk of Kidney Disease From Cardiovascular Disease
Park, M. (2015) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2015.01.014
Warum die rheumatoide Arthritis den Kardiologen braucht
Pieringer, H., & Hoppe, U. C. (2012) · Der Kardiologe · doi:10.1007/s12181-012-0460-5
Assessing individual cardiac risk using extra-cardiac arterial imaging
Nelson, M. R., Hurst, R. T., & Mookadam, F. (2010) · Expert Review of Cardiovascular Therapy · doi:10.1586/erc.10.16
Gender-specific association between carotid intima-media thickness and Reynolds risk score
Ramadan, M. M., El-Shahat, N., Daoud, E. M., Omar, A. A., & Bassam, I. (2011) · The Egyptian Heart Journal · doi:10.1016/j.ehj.2011.08.023
Optimizing lipid-lowering therapy in the prevention of coronary heart disease
Packard, C. J. (2010) · Expert Review of Clinical Pharmacology · doi:10.1586/ecp.10.51
Cardiovascular risk prediction: the old has given way to the new but at what risk-benefit ratio?
Yeboah, J. (2014) · Research Reports in Clinical Cardiology · doi:10.2147/rrcc.s44909
Physiopathologie de la maladie athéro-thrombotique : quelques données fondamentales pour comprendre le risque résiduel
Hello, C. L., NGuyen, V., & Maiza, D. (2010) · Médecine des Maladies Métaboliques · doi:10.1016/s1957-2557(10)70079-1
Estimating the clinical effect of incorporating a new risk marker into therapeutic decisions via a risk reclassification strategy
Williams, B. A. (2013) · Journal of Medical Statistics and Informatics · doi:10.7243/2053-7662-1-5
Assessment of the JUPITER Trial
Forman, D. E., & Gaziano, J. M. (2010) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-010-0126-4
Self-citation
Infiammazione e lipidi nella patologia coronarica. Fattori di rischio, cause scatenanti o target terapeutici?
Filardi, P. P., Cecere, M., Savarese, G., D’Amore, C., Parente, A., Conte, S., & Coutsoumbas, G. V. (2010) · Giornale italiano di cardiologia · doi:10.1714/664.7725
Avaliação da aterosclerose subclínica coronariana e carotídea em portadores de hipercolesterolemia familiar: análise pela angiotomografia coronária, rigidez arterial e espessura íntima-média carotídea
Miname, M. H. (2010) · doi:10.11606/t.5.2010.tde-12012011-161846
Geneetilistel markeritel põhinev südame isheemiatõve riski hindamine Eesti Geenivaramu kohordis
Tähiste, A. (2014) · DSpace repository (University of Tartu)
Deep Structure and Smart Mechanisms: Designing Perspicacious Systems
Flach, J. M. (2012) · ASME Biennial Conference on Engineering Systems Design and Analysis (ESDA) · doi:10.1115/esda2012-83015
L'évaluation du risque cardiovasculaire pour une stratification optimale des patients à risque faible et modéré Point de vue CLINIQUE
McPherson, P. R. (2009)
Genetic risk profiles for coronary heart disease
Tikkanen, E. (2013) · Työväentutkimus Vuosikirja
Subclinical Atherosclerosis and Primary Prevention
Tarantini, G., Buja, P., & Facchin, M. (2012) · Springer eBooks · doi:10.1007/978-88-470-2522-6_3
Srce i krvni Sudovi
Beleslin, B., Deljanin, M., Kanjuh, V., Parapid, B. J., Giga, V. L., Prostran, M. S., Angelkov, L., Balinovac, J., Bikicki, M., Ambrosio, G., et al. (2013)
Editor's Perspective Three Reasons to Abandon Low-Density Lipoprotein Targets An Open Letter to the Adult Treatment Panel IV of the National Institutes of Health
Hayward, R. A., & Krumholz, H. M. (2012)
Adult Treatment Panel IV of the National Institutes of Health Three Reasons to Abandon Low-Density Lipoprotein Targets : An Open Letter to the
Hayward, R. A., & Krumholz, H. M. (2012)
Review Article: C-reactive protein and coronary heart disease - risk marker or risk factor?
Davis, J. F., Vidyasagar, S., & Maiya, A. G. (2015)
Predicción del riesgo de Enfermedad Cardiovascular en la mujer: ¿Qué papel tienen los nuevos biomarcadores? Cardiovascular disease risk prediction in women: is there a role for novel biomarkers?
Paynter, N. P., Everett, B. M., & Cook, N. R. (2014)
Self-citation
The Role of Inflammatory Cytokines in Diabetic Nephropathy: Potential Use as Predictive Markers for Early Detection and Progression
Elmarakby, A. A., Baban, B., Liu, J. Y., & Mozaffari, M. S. (2013) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-94-007-5971-8_9
CARDIOVASCULAR RISK ASSESSMENT – ADDITION OF CHRONIC KIDNEY DISEASE AND RACE TO THE FRAMINGHAM EQUATION
Drawz, P. E. (2009) · OhioLink ETD Center (Ohio Library and Information Network)
The prevalence of laboratory cardiovascular risk factors and associated parameters
Motamedi, M. R., Khatami, M., Safi, M., Valaee, N., & Biglari, M. (2011) · Research in Medicine
UNIVERSIDADE FEDERAL DE GOIÁS PROGRAMA DE PÓS-GRADUAÇÃO EM MEDICINA TROPICAL
Pública, E. S., Ribeiro, P. M. A., & Pacheco, G. (2010)
Correlação de obesidade, pressão arterial e marcadores inflamatórios em população jovem, portadora de síndrome de Down
Saraiva, D. J. B. (2015) · doi:10.11606/t.5.2015.tde-26102015-154517
Effective Lipid-lowering Therapy in High-risk Patients
Kastelein, J. J. P., Arsenault, B. J., & Tardif, J. (2011) · European Journal of Cardiovascular Medicine · doi:10.5083/ejcm.20424884.211
Application of Reynolds Risk Score for younger generation with different ethnicities
Kawada, T. (2012) · Lupus · doi:10.1177/0961203312445231
Взаємозв’язок між циркулюючим рівнем васкулярного ендотеліального фактора росту-1 і концентрацією високочутливого С-реактивного протеїну у пацієнтів із гіпертонічною хворобою ІІІ стадії
Berezin, A. Е., & Lisova, O. O. (2013) · The Scientific Issues of Ternopil Volodymyr Hnatiuk National Pedagogical University Series pedagogy
Assessment Causality and Quantifying Contribution to Risk Biomarkers and Cardiovascular Disease: Determining
Shah, S. H., & de Lemos, J. A. (2009)
MARCADORES CARDIACOS Y RIESGO CARDIOVASCULAR
Markers, C. (2016)
Entzündung und Atherosklerose - Update 2015
Ka, K., Sp, K., Wojta, J., & Speidl, W. S. (2015) · Journal für Kardiologie (Krause & Pachernegg GmbH)
How to Estimate Cardiovascular Risk
da Luz, P. L., & Fialdini, R. C. (2015) · Springer eBooks · doi:10.1007/978-3-319-22357-5_4
Análise comparativa da resposta de marcadores metabólicos, de aterogênese e de resistência à insulina à Dieta Cardioprotetora Brasileira - DICA-Br - na prevenção cardiovascular secundária
Fernandes, M. B. R. (2016) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/d.6.2016.tde-01122015-104554
Use of a genetic risk score to predict adverse events post myocardial infarction and age of first myocardial infarction
Labos, C. (2014) · eScholarship@McGill (McGill) · doi:10.82308/49679
Assessment of Cardiovascular Risk Beyond Lipid Panel in Cardio-Oncology Patients
Wei, J. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-803547-4.00016-1
Predicting cardiometabolic risk: The evolution continues
Hiserote, P., & Clearfield, M. B. (2009)
Aviation Relevance of Genetic Risk Scores for Cardiovascular Disease
Burian, D. M. (2015) · ROSA P
Markers of Progression and Regression of Atherosclerotic Cardiovascular Disease in Patients with Inflammatory Joint Diseases
Ikdahl, E. (2017) · NORA - Norwegian Open Research Archives
Aterosclerosis: biomarcadores plasmáticos emergentes Atherosclerosis: emerging plasma biomarkers
Benozzi, S. F., & Coniglio, R. I. (2010)
Microalbuminuria predictor of cardiovascular disease in Iraqi type 2 diabetes mellitus
Hasan, E. J. (2022) · journal of the college of basic education · doi:10.35950/cbej.v21i89.6674
Short-term Cardio-Vascular Risk Score Changes in Type 2 Diabetic Patients on Empaglifozin: A Real-Life Clinical Experience
Fusco, A., Colarusso, S., Piscopo, M., Improta, M. R., Corigliano, M., Martedì, E., Oliva, D., Santorelli, A., Simonetti, R. G., Giammarco, A., et al. (2017) · Heart Research - Open Journal · doi:10.17140/hroj-4-141
The Uncertainty of Cardiovascular Disease Risk Calculation—What is the Best Risk Model for the Individual?
LaFleur, R. S., & Goshko, L. S. (2018) · Journal of Engineering and Science in Medical Diagnostics and Therapy · doi:10.1115/1.4039103
Should Coronary Calcium Scoring Be Used as the Central Tool for Cardiac Risk Assessment?
Aroney, C. N. (2018) · Heart Lung and Circulation · doi:10.1016/j.hlc.2018.06.1053
Personalized Approach to Statin Selection in Primary Prevention: Genetic Risk Scores Vs Imaging Risk Scores
Cesena, F. Y., & Bittencourt, M. S. (2018) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-018-0591-8
Prediction of clinical outcomes of patients treated with percutaneous coronary intervention for ST-Elevation myocardial infarction using familial history of premature coronary artery disease
Sohrabi, B., Separham, A., Habibolahi, H., Enamzadeh, E., Ghamari, B., & Shayan, F. K. (2018) · Journal of Analytical Research in Clinical Medicine · doi:10.15171/jarcm.2018.028
Cardiac computed tomography in asymptomatic siblings of patients with premature coronary disease: illustrations and current knowledge
Higny, J., Dupont, M., & Guédès, A. (2019) · Acta cardiologica. Supplementum · doi:10.1080/00015385.2018.1561350
Clinical Application of the Coronary Artery Calcium Score and Implications for Cardiovascular Disease Prevention
Morris, P. B., & Shapiro, M. D. (2019) · Contemporary medical imaging · doi:10.1007/978-1-60327-237-7_23

Authors: Ridker, P. M., Paynter, N. P., Rifai, N., Gaziano, J. M., & Cook, N. R.
Affiliations: Brigham and Women's Hospital (US)
ORCID: Ridker, Paul M
Paynter, Nina P.
Rifai, Nader
Gaziano, J. Michael
Cook, Nancy R.
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2008-11-25
Volume: 118
Issue: 22
Pages: 2243-2251
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/circulationaha.108.814251
PMC: PMC2752381
OpenAlex: W2096807144
Semantic Scholar: 4e13b2445d617740f45915eafd75712fdf825998
Cited by: 841
References: 27
Citations by year: 2026: 11 · 2025: 22 · 2024: 20 · 2023: 25 · 2022: 23 · 2021: 32 · 2020: 31 · 2019: 39 · 2018: 42 · 2017: 37 · 2016: 47 · 2015: 68 · 2014: 63 · 2013: 53 · 2012: 92
FWCI: 80.90
Type: journal article
Language: en
Open access: bronze
doi.org
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (R01CA097193)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Health Promotion and Cardiovascular Prevention
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: Reynolds Risk Score, cardiovascular risk prediction, men, family history of myocardial infarction, coronary artery disease, risk reclassification, net reclassification improvement, coronary risk factors, hypertriglyceridemia, hypercholesterolemia, LDL cholesterol, HDL cholesterol, blood pressure, smoking, non-diabetic men
MeSH terms: C-Reactive Protein, Cardiovascular Diseases, Female, Follow-Up Studies, Humans, Inflammation, Life Style, Male, Predictive Value of Tests, Prospective Studies, Sex Characteristics, Biomarkers, Likelihood Functions, Risk Assessment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

C-Reactive Protein and Parental History Improve Global Cardiovascular Risk Prediction: The Reynolds Risk Score for Men

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks